Cufosa 70mg Tablet
Prescription Required
Product introduction
Cufosa 70mg Tablet is used to prevent or treat weakening of the bones (osteoporosis), caused by menopause or use of steroids), and treat Paget's disease of the bone. This medicine helps regulate bone remodeling by reducing bone turnover. It also alleviate bone pain, reduce fractures, and improve bone density.
Cufosa 70mg Tablet is used to treat osteoporosis (disease causing weak bones)
Cufosa 70mg Tablet is used to treat osteoporosis (disease causing weak bones)
Uses of Cufosa Tablet
- Treatment of Osteoporosis
- Treatment of Paget's disease
Benefits of Cufosa Tablet
In Treatment of Osteoporosis
Osteoporosis is a common condition that weakens bones, making them fragile and more likely to break. It often occurs in women after menopause or who are taking steroids. This condition can be treated with bone-strengthening medicines. Cufosa 70mg Tablet slows down the rate at which bone is broken down in your body. This maintains bone density and reduces your risk of breaking a bone. You can also help improve the strength of your bones by doing regular exercise (especially weight-bearing exercise), eating healthy foods containing calcium and Vitamin D, and reducing your consumption of alcohol and tobacco. Supplements of calcium and Vitamin D3 are also effective.
In Treatment of Paget's disease
Paget's disease is a chronic bone disorder characterized by abnormal bone remodeling. It causes bones to become larger, weaker, and more brittle. Symptoms of Paget's disease include bone pain, deformities, and fractures. Cufosa 70mg Tablet helps control bone regeneration. When taken regularly, it can also alleviate bone pain, reduce fractures, improve bone density, and slow down the progress of the disease.
Side effects of Cufosa Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Cufosa
- Diarrhea
- Headache
- Heartburn
- Musculoskeletal (bone, muscle or joint) pain
- Indigestion
How to use Cufosa Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Cufosa 70mg Tablet is to be taken empty stomach.
How Cufosa Tablet works
Cufosa 70mg Tablet is a bisphosphonate. It works by suppressing the activity of osteoclasts, cells that cause destruction of bone. This strengthens the bones and minimizes the risk of fractures.
Safety advice
Alcohol
SAFE
Consuming alcohol with Cufosa 70mg Tablet does not cause any harmful side effects.
Pregnancy
CONSULT YOUR DOCTOR
Cufosa 70mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
SAFE IF PRESCRIBED
Cufosa 70mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
If you are taking Cufosa 70mg Tablet during breastfeeding, monitor baby's blood calcium levels during the first two months.
If you are taking Cufosa 70mg Tablet during breastfeeding, monitor baby's blood calcium levels during the first two months.
Driving
UNSAFE
Cufosa 70mg Tablet may cause side effects which could affect your ability to drive.
Cufosa 70mg Tablet is not expected to have any effects but in rare cases, it may cause dizziness, severe muscle, joint and bone pain and eye pain or inflammation. This may affect your ability to drive.
Cufosa 70mg Tablet is not expected to have any effects but in rare cases, it may cause dizziness, severe muscle, joint and bone pain and eye pain or inflammation. This may affect your ability to drive.
Kidney
CAUTION
Cufosa 70mg Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Cufosa 70mg Tablet may be needed. Please consult your doctor.
Dose adjustment is not recommended in patients with mild to moderate kidney disease.
Dose adjustment is not recommended in patients with mild to moderate kidney disease.
Liver
SAFE IF PRESCRIBED
Cufosa 70mg Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Cufosa 70mg Tablet may not be needed in these patients. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Cufosa 70mg Tablet
₹37.5/Tablet
Osteofos 70 Tablet
Cipla Ltd
₹58.73/tablet
67% costlier
Bifosa 70 Tablet
Troikaa Pharmaceuticals Ltd
₹48.75/tablet
38% costlier
Alenost 70mg Tablet
Macleods Pharmaceuticals Pvt Ltd
₹25.21/tablet
28% cheaper
Alenfos 70mg Tablet
Marc Laboratories Pvt Ltd
₹29/tablet
18% cheaper
Rafomax 70mg Tablet
Taj Pharma India Ltd
₹24/tablet
32% cheaper
Quick tips
- Your doctor has prescribed Cufosa 70mg Tablet to make your bones stronger and lower the risk of fractures.
- Take it in the morning at least 30 minutes before eating or drinking anything.
- Maintain an upright posture for 30 minutes after taking the medication so the medicine does not irritate your food pipe.
- It may cause the amount of calcium in your blood to fall. Take calcium-rich food in your diet and have regular blood tests to monitor the level of calcium in your blood.
- It is important to look after your mouth and teeth while you are taking this medicine. Have regular dental check-ups and inform your dentist about taking Cufosa 70mg Tablet.
Fact Box
Chemical Class
Bisphosphonate Derivative
Habit Forming
No
Therapeutic Class
PAIN ANALGESICS
Action Class
Bone resorption inhibitor -Bisphosphonates
Patient concerns
FAQs
How to take Cufosa 70mg Tablet?
It should be taken in the morning after getting up on an empty stomach with a full glass of water. Do not lie down and stay fully upright for at least 30 minutes after swallowing the medicine. Avoid taking any food or medication for the next 30 mins after taking this medicine. Take this medicine only after consulting the doctor and follow the instructions advised.
Why can you not lie down after taking Cufosa 70mg Tablet?
No, one should not lie down after taking Cufosa 70mg Tablet. This is because there is a possibility that the medication might come back up into the esophagus (food pipe) and even damage the esophagus. Staying upright will help the medicine to settle down quickly in your stomach and prevent side effects like heartburn and pain.
Does Cufosa 70mg Tablet cause hair loss?
Yes, Cufosa 70mg Tablet can cause hair loss, but this is not a common side effect. If you experience hair loss while taking this medication immediately report to your doctor and follow the advice given.
Can Cufosa 70mg Tablet be used in pregnant women?
Cufosa 70mg Tablet should be avoided during pregnancy. Enough data is not available regarding the use of Cufosa 70mg Tablet in pregnant women. You should consult your doctor if you are pregnant or planning to get pregnant before taking this medication.
Does Cufosa 70mg Tablet cause cancer/ hair loss/ tiredness/ increase in blood pressure?
Cufosa 70mg Tablet has a side effect of causing hair loss and tiredness. However, it is not known to cause cancer or increase in blood pressure. Consult your doctor if you experience such side effects.
Related ayurvedic ingredients
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Alendronic acid. Whitehouse, New Jersey: Merck Sharp & Dohme Corp.; 1995 [revised Mar. 2016]. [Accessed 02 Apr. 2019] (online) Available from:
- Wilkins Parker LR, Preuss CV. Alendronate. [Updated 2023 Mar 24]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. [Accessed 09 Jun, 2023] (online) Available from:
- CiplaMed. Alendronate [Product Informatiom]. [Accessed 09 Jun, 2023] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 02 Apr. 2019] (online) Available from:
Marketer details
Name: Cubit Healthcare
Address: 1, CUBIT HOUSE, 13/369, Panchratna Estate, B/h Ankoor Oil Factory, Opp. Bhagyoday Hotel, Changodar, Ahmedabad-382210 (Guj.) INDIA.
Country of origin: India
Lab tests offered by us
Related/Popular tests
MRP
₹150
Inclusive of all taxes
4.0 tablets in 1 strip
SOLD OUT